RDIF expects 50 Mn doses a month of Sputnik V vaccine production in India

By: |
April 13, 2021 8:48 PM

RDIF CEO Kirill Dmitriev in a virtual press conference said besides five drug companies that the Russian firm had ties ups with, they are looking for a couple of more firms for the possible production pacts.

sputnik vIn September 2020, Dr. Reddys and RDIF entered into a partnership to conduct clinical trials of the Sputnik V. (Photo source: Reuters)

The Russian Direct Investment Fund (RDIF) on Tuesday said it expects over 50 million doses of Sputnik V vaccine to be manufactured in India by this summer.

The Drug Controller General of India (DCGI) on Monday registered the vaccine under the emergency use authorisation procedure, based on results of clinical trials in Russia, as well as positive data of additional Phase III local clinical trials in India conducted in partnership with Dr Reddy’s Laboratories.

RDIF CEO Kirill Dmitriev in a virtual press conference said besides five drug companies that the Russian firm had ties ups with, they are looking for a couple of more firms for the possible production pacts.

“We almost think sputnik V is an Indian-Russian vaccine, because lots of production of sputnik V will be done in India.

We publicly announced five production partnerships in India with some of the largest Indianpharmaceutical companies,” Dmitriev said.

“We believe more than 50 million doses a month (to be manufactured) in the summer (in a couple of months). This is our plan.

By summer we expect to manufacture 50 million doses or more of sputnik V a month in India, he said.

Replying to a query, he said some of the Indian firms have started production of the vaccine under the strict quality checks.

In September 2020, Dr. Reddys and RDIF entered into a partnership to conduct clinical trials of the Sputnik V, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the rights for distribution of the first 100 million doses in India.

Later it was enhanced to 125 million.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Mumbai reports less than 1,000 COVID-19 cases after two and half months
2Tamil Nadu clocks 33,059 new COVID-19 infections; 364 fatalities push toll to 18,369
3States given 6.1 lakh Remdesivir vials, 15,801 oxygen cylinders, over 11,000 concentrators received as foreign aid: Centre